Track topics on Twitter Track topics that are important to you
Via Correggio, 43
German family-owned drugmaker Grünenthal has decided to end its partnership with US firm Depomed for…
Developed by Grünenthal, Tramal ®is a well-established analgesic for the treatment of moderate to severe pain. It is the only international brand of tramadol Read more...
Privately-held firms Grünenthal and Mundipharma have agreed a licensing and distribution deal for the…
German firm GrÃnenthal has signed a license and distribution deal with Mundipharma for the formerâs analgesic Tramal (tramadol).
Family-owned German pharma Grünenthal is to distribute, promote and sell Merck & Co’s women health…
Mundipharma has agreed to market and distribute Grünenthal’s Tramal (tramadol) in China from 1 May 2018.
US-based firm Mundipharma is set to take over commercialisation and distribution duties for the analgesic Tramal (tramadol) in China on behalf of Grünenthal, it has emerged. Mundipharma has signed a ...
The Zalviso® Sufentanil Sublingual Tablet System (SSTS) (Grünenthal Italia, Milan, Italy) is a patient-controlled analgesia (PCA) system approved in September 2015 by the European Commis...
The GrÃ¼nenthal Group is an independent, family-owned company, headquartered in Aachen, Germany. It is present in 32 countries with affiliates in Europe, Latin America and the U...
Grünenthal è una società farmaceutica indipendente, basata sulla ricerca con operazioni internazionali. E' sempre stata una società a capitale privato fin dalla sua fondazione nel 1946. I prodotti...
We have published hundreds of Grünenthal news stories on BioPortfolio along with dozens of Grünenthal Clinical Trials and PubMed Articles about Grünenthal for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Grünenthal Companies in our database. You can also find out about relevant Grünenthal Drugs and Medications on this site too.